Skip to main content
. Author manuscript; available in PMC: 2011 Dec 15.
Published in final edited form as: Clin Cancer Res. 2010 Oct 29;16(24):6049–6059. doi: 10.1158/1078-0432.CCR-10-2435

Figure 4. Intracerebral (ic) xenograft initiated from CD133+ GBMJ1 TSCs.

Figure 4

A representative mouse was euthanized at the initial signs of morbidity (94 days after implantation); the brain tumor was then prepared for histological analyses. Left panels: H&E staining and Right panels: immunoflorescent analyses of GFAP, β-III tubulin and CD133 expression with nuclei counterstained with DAPI (blue); 20x magnification with insert at 63x.

HHS Vulnerability Disclosure